Changes in BRCA2 expression during progression of the cell cycle
- PMID: 9168997
- DOI: 10.1006/bbrc.1997.6544
Changes in BRCA2 expression during progression of the cell cycle
Abstract
It has been shown that genetic alterations in BRCA1 and BRCA2 can predispose an individual to develop breast cancer. We investigated the expression of both BRCA2 and BRCA1 during the progression of the cell cycle by northern blot analysis. In MCF-10F (normal breast epithelial cell line) and MCF-7 (breast cancer cell line) cells the expression of BRCA2 RNA was low in G0 and early G1 phases then up-regulated at the G1/S phase junction. Expression of BRCA2 was maintained at relatively high levels when cells progressed through S and G2/M phases. For MCF-7 cells, the level of BRCA2 transcript decreased as cells were released from nocodazole-mediated metaphase arrest. This is consistent with the observation of low but detectable BRCA2 RNA level in G1 phase of the cell cycle. For both cell lines, the patterns of RNA expression of BRCA1 and BRCA2 were similar during the proliferation phase of cell cycle. However, the transcripts from both genes were undetectable in quiescent cells. These results suggest important functions for both BRCA2 and BRCA1 in regulation of cell growth.
Similar articles
-
Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents.Oncogene. 1998 Apr 30;16(17):2229-41. doi: 10.1038/sj.onc.1201752. Oncogene. 1998. PMID: 9619832
-
Cell cycle control of BRCA2.Cancer Res. 1996 Oct 15;56(20):4590-4. Cancer Res. 1996. PMID: 8840967
-
[Effects of lovastatin on cell cycle distribution in MCF-7 cells transfected with BRCA1].Ai Zheng. 2004 Aug;23(8):924-8. Ai Zheng. 2004. PMID: 15301716 Chinese.
-
Lessons learned from BRCA1 and BRCA2.Oncogene. 2000 Dec 11;19(53):6159-75. doi: 10.1038/sj.onc.1203968. Oncogene. 2000. PMID: 11156530 Review.
-
[Breast cancer genetics. BRCA1 and BRCA2: the main genes for disease predisposition].Rev Invest Clin. 2001 Jan-Feb;53(1):46-64. Rev Invest Clin. 2001. PMID: 11332051 Review. Spanish.
Cited by
-
DNA double-strand break repair as determinant of cellular radiosensitivity to killing and target in radiation therapy.Front Oncol. 2013 May 10;3:113. doi: 10.3389/fonc.2013.00113. eCollection 2013. Front Oncol. 2013. PMID: 23675572 Free PMC article.
-
What is known about melatonin, chemotherapy and altered gene expression in breast cancer.Oncol Lett. 2017 Apr;13(4):2003-2014. doi: 10.3892/ol.2017.5712. Epub 2017 Feb 10. Oncol Lett. 2017. PMID: 28454355 Free PMC article.
-
Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains.Proc Natl Acad Sci U S A. 1997 Oct 28;94(22):12075-80. doi: 10.1073/pnas.94.22.12075. Proc Natl Acad Sci U S A. 1997. PMID: 9342365 Free PMC article.
-
The role of the redox/miR-6855-3p/PRDX5A axis in reversing SLUG-mediated BRCA2 silencing in breast cancer cells.Cell Commun Signal. 2020 Jan 27;18(1):15. doi: 10.1186/s12964-019-0493-5. Cell Commun Signal. 2020. PMID: 31987042 Free PMC article.
-
Yeast as a Model to Unravel New BRCA2 Functions in Cell Metabolism.Front Oncol. 2022 Jun 6;12:908442. doi: 10.3389/fonc.2022.908442. eCollection 2022. Front Oncol. 2022. PMID: 35734584 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous